PE20050054A1 - Indoles 2,7-sustituidos - Google Patents

Indoles 2,7-sustituidos

Info

Publication number
PE20050054A1
PE20050054A1 PE2003000929A PE2003000929A PE20050054A1 PE 20050054 A1 PE20050054 A1 PE 20050054A1 PE 2003000929 A PE2003000929 A PE 2003000929A PE 2003000929 A PE2003000929 A PE 2003000929A PE 20050054 A1 PE20050054 A1 PE 20050054A1
Authority
PE
Peru
Prior art keywords
piperazin
indol
compounds
benzenosulfonil
alkyl
Prior art date
Application number
PE2003000929A
Other languages
English (en)
Inventor
Ann Marie Madera
Robert James Weikert
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20050054A1 publication Critical patent/PE20050054A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

REFERIDA A COMPUESTOS DE FORMULA I, n ES 0-2; p ES 1-2; R1 ES ARILO SUSTITUIDO O HETEROARILO; R2 HETEROCICLILO OPCIONALMENTE SUSTITUIDO; R3 H, ALQUILO, -C(=O)-R5, ENTRE OTROS; R5 ES ALCOXILO, ARILO, ARILOXILO, ALQUILO. CADA R4 ES H, HIDROXILO, CIANO, ENTRE OTROS. TAMBIEN REFERIDA A COMPOSICIONES QUE LO COMPRENDEN Y PROCEDIMIENTOS PARA SU PREPARACION. SON COMPUESTOS PREFERIDOS: 2-BENCENOSULFONIL-7-PIPERAZIN-1-IL-1H-INDOL; 2-(2,3-DICLORO-BENCENOSULFONIL)-7-PIPERAZIN-1-IL-1H-INDOL Y 7-PIPERAZIN-1-IL-2-(2-TRIFLUOROMETIL-BENCENOSULFONIL)-1H-INDOL. DICHOS COMPUESTOS SON UTILES EN TRASTORNOS DE LA MEMORIA, DEL TRACTO GASTROINTESTINAL, LA ENFERMEDAD DE HUNTINGTON, CASOS DE OBESIDAD, ENTRE OTROS
PE2003000929A 2002-09-17 2003-09-12 Indoles 2,7-sustituidos PE20050054A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41123902P 2002-09-17 2002-09-17

Publications (1)

Publication Number Publication Date
PE20050054A1 true PE20050054A1 (es) 2005-02-18

Family

ID=32030655

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000929A PE20050054A1 (es) 2002-09-17 2003-09-12 Indoles 2,7-sustituidos

Country Status (29)

Country Link
US (1) US7247651B2 (es)
EP (1) EP1587788B9 (es)
JP (1) JP4327091B2 (es)
KR (1) KR100686758B1 (es)
CN (1) CN1314669C (es)
AR (1) AR041255A1 (es)
AT (1) ATE362469T1 (es)
AU (1) AU2003273855B2 (es)
BR (1) BR0314352A (es)
CA (1) CA2496765A1 (es)
DE (1) DE60313895T2 (es)
DK (1) DK1587788T3 (es)
ES (1) ES2287518T3 (es)
GT (1) GT200300199A (es)
HK (1) HK1083500A1 (es)
HR (1) HRP20050229A2 (es)
MX (1) MXPA05002696A (es)
MY (1) MY138826A (es)
NO (1) NO20050666L (es)
NZ (1) NZ537982A (es)
PA (1) PA8582201A1 (es)
PE (1) PE20050054A1 (es)
PL (1) PL376020A1 (es)
PT (1) PT1587788E (es)
RU (1) RU2327685C2 (es)
TW (1) TWI249402B (es)
UY (1) UY27980A1 (es)
WO (1) WO2004026830A1 (es)
ZA (1) ZA200501306B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7452888B2 (en) 2002-03-27 2008-11-18 Glaxo Group Limited Quinoline derivatives and their use as 5-ht6 ligands
KR101157272B1 (ko) 2003-07-22 2012-06-15 아레나 파마슈티칼스, 인크. 5?ht2a 세로토닌 수용체의 조절자로서 이와 관련된질환의 예방 및 치료에 유용한 디아릴 및 아릴헤테로아릴우레아 유도체
BRPI0417858B1 (pt) * 2003-12-23 2017-10-10 H. Lundbeck A/S Derivative compounds of aniline and pharmaceutical composition that understand it
AR052308A1 (es) * 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
US7713954B2 (en) * 2004-09-30 2010-05-11 Roche Palo Alto Llc Compositions and methods for treating cognitive disorders
JP4975626B2 (ja) 2004-09-30 2012-07-11 エフ.ホフマン−ラ ロシュ アーゲー 認知障害の処置用の組成物および方法
WO2006062481A1 (en) * 2004-12-09 2006-06-15 Biovitrum Ab New benzofuran derivatives and their use in the treatment of obesity, type ii diabetes and cns disorders .
US7629473B2 (en) * 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
AR054393A1 (es) * 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
BRPI0718776A2 (pt) * 2006-11-09 2013-12-03 Hoffmann La Roche Derivados de indol e benzofurano 2-carboxamida
EP2508177A1 (en) 2007-12-12 2012-10-10 Glaxo Group Limited Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
CN103288707B (zh) * 2013-05-28 2015-12-23 浙江大学 一种3-苯巯基吲哚衍生物的制备方法
US9663498B2 (en) 2013-12-20 2017-05-30 Sunshine Lake Pharma Co., Ltd. Aromatic heterocyclic compounds and their application in pharmaceuticals
WO2016004882A1 (en) 2014-07-08 2016-01-14 Sunshine Lake Pharma Co., Ltd. Aromatic heterocyclic derivatives and pharmaceutical applications thereof
EP4119141A1 (en) 2015-06-12 2023-01-18 Axovant Sciences GmbH Nelotanserin for the prophylaxis and treatment of rem sleep behavior disorder
JP2018520187A (ja) 2015-07-15 2018-07-26 アクソヴァント サイエンシーズ ゲゼルシャフト ミット ベシュレンクテル ハフツングAxovant Sciences GmbH 神経変性疾患と関連する幻覚の予防および処置のために有用な5−ht2aセロトニン受容体のモジュレーターとしてのジアリールおよびアリールヘテロアリール尿素誘導体

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3155008B2 (ja) 1994-07-26 2001-04-09 ファイザー・インコーポレーテッド セロトニンアゴニストおよびアンタゴニストとしての4−インドール誘導体
US6114532A (en) * 1998-02-03 2000-09-05 Boehringer Ingelheim Pharma Kg Bicyclic heterocycles, the preparation thereof, and their use as pharmaceuticals
CA2336117A1 (en) 1998-06-30 2000-01-06 Sidney Xi Liang Piperidine derivatives having effects on serotonin related systems
FR2788772B1 (fr) * 1999-01-26 2001-03-02 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB9912413D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
CZ20033529A3 (cs) * 2001-06-07 2004-04-14 F. Hoffman-La Roche Ag Nové deriváty indolu s afinitou k receptoru 5-HT6
BR0210411A (pt) * 2001-06-15 2004-08-17 Hoffmann La Roche Derivados 4-piperazinilindol com afinidade para o receptor 5-ht6
WO2003013510A1 (en) * 2001-08-07 2003-02-20 Smithkline Beecham P.L.C. 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
US7943639B2 (en) 2002-06-20 2011-05-17 Proximagen Limited Compounds

Also Published As

Publication number Publication date
JP4327091B2 (ja) 2009-09-09
AU2003273855A1 (en) 2004-04-08
RU2005111587A (ru) 2005-11-20
NO20050666L (no) 2005-03-11
US20040063724A1 (en) 2004-04-01
KR100686758B1 (ko) 2007-02-26
TWI249402B (en) 2006-02-21
US7247651B2 (en) 2007-07-24
RU2327685C2 (ru) 2008-06-27
DE60313895D1 (de) 2007-06-28
CA2496765A1 (en) 2004-04-01
EP1587788B1 (en) 2007-05-16
EP1587788B9 (en) 2007-10-24
MXPA05002696A (es) 2005-05-05
ES2287518T3 (es) 2007-12-16
EP1587788A1 (en) 2005-10-26
CN1681782A (zh) 2005-10-12
GT200300199A (es) 2006-08-22
HK1083500A1 (en) 2006-07-07
AU2003273855B2 (en) 2009-01-15
KR20050057357A (ko) 2005-06-16
ZA200501306B (en) 2006-05-31
BR0314352A (pt) 2005-07-19
TW200410685A (en) 2004-07-01
WO2004026830A1 (en) 2004-04-01
PT1587788E (pt) 2007-08-20
ATE362469T1 (de) 2007-06-15
DK1587788T3 (da) 2007-09-24
AR041255A1 (es) 2005-05-11
MY138826A (en) 2009-07-31
CN1314669C (zh) 2007-05-09
JP2006503052A (ja) 2006-01-26
DE60313895T2 (de) 2008-01-17
HRP20050229A2 (hr) 2006-04-30
NZ537982A (en) 2007-05-31
PL376020A1 (en) 2005-12-12
UY27980A1 (es) 2004-03-31
PA8582201A1 (es) 2004-04-23

Similar Documents

Publication Publication Date Title
PE20050054A1 (es) Indoles 2,7-sustituidos
PE20061096A1 (es) Derivados de oxiindol como agonistas 5-ht4
BRPI0417323A (pt) indóis, 1h-indazóis, 1,2-benzisoxazóis, e 1,2-benzisotiazóis, composto, composição farmacêutica e usos dos mesmos
TR200001264T2 (tr) Alzheimer hastalığının antermotem teşhisi için bileşikler.
PE20080361A1 (es) Compuestos derivados de purina como activadores del receptor de adenosina a2a
ATE469892T1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
AR058719A1 (es) Derivados de isoxazol-4-il-oxadiazol
DE602004007808D1 (de) Neue gamma secretase inhibitoren
PE20040691A1 (es) 4-piperazinilbencenosulfonilindoles afines con el receptor 5-ht6
DE602006006712D1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
MA31766B1 (fr) Composés organiques
CY1108808T1 (el) Ενωσεις μοτιλιδης
PE20060653A1 (es) Derivados triciclicos condensados como moduladores del receptor 5-ht1
EA200600071A1 (ru) Производные n-фенилпиперазина и способы профилактики или лечения заболеваний, связанных с 5ht-рецептором
PE20030471A1 (es) Compuesto de imidazopiridin como moduladores del receptor 5-ht4
PE20060625A1 (es) Derivados de benzazepina como antagonistas y/o agonistas del receptor h3 de histamina
PE20001543A1 (es) Derivados de piridopiranoacepinas, su preparacion y su aplicacion en terapeutica
GT200400146A (es) Derivados sustituidos del dioxido de tiazol-benzoisotiazol, procedimiento para su preparacion y su uso
PE20001583A1 (es) Derivados de la 1-arenosulfonil-2-arilo-pirrolidina y de la piperidina
TW200637817A (en) 5-aminoindole derivatives
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
ATE396183T1 (de) Chromanderivate und ihre verwendung als liganden des 5-ht-rezeptors
CY1112449T1 (el) Υποκατεστημενα ν-βενζο [d] ισοξαζολ-3-υλ-αμινο παραγωγα ως αναστολεις υποδοχεων mglur5, σεροτονινης-(5-ητ) και νοραδρεναλινης και η χρηση αυτων για την παραγωγη φαρμακων
PE20030718A1 (es) Lactamas como antagonistas de taquiquininas
CL2003002565A1 (es) Compuestos derivados de 3h-quinazolin-4-ona, su proceso de preparacion, composicion farmaceutica que los contiene, y uso en el tratamiento y prevencion de enfermedades mediadas por inhibidores de mao-b, tales como la enfermedad de alzheimer y demenci

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed